Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Clinical trial NCT00478725 · COMPLETED

Trial details

NCT number: NCT00478725
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2007-07-18
Primary completion: 2008-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.